+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Coagulation Testing Market - Forecasts From 2018 to 2023

  • ID: 4718313
  • Report
  • November 2018
  • Region: Global
  • 105 pages
  • Knowledge Sourcing Intelligence LLP
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now


  • Abbott
  • Coagulation Sciences LLC
  • Diagnostica Stago, S.A.S.
  • r2 Diagnostics
  • Roche Diagnostics
  • RUSNANO Group
  • MORE
The global coagulation testing market is projected to grow at a CAGR of 7.65%, increasing from US$1,955.420 million in 2017 to US$3,042.760 million in 2023. Coagulation is the blood’s ability to clot and prevent excessive bleeding. Coagulation testing refers to the measure of blood’s ability to clot, and the time it takes to clot. Clotting disorders can cause excessive bleeding or may lead to clot formation and can be fatal in either of the two scenario. Thus, coagulation tests are done to assess the blood clotting function in patients. The global coagulation testing market is expected to witnessing significant growth during the giving forecast period owing to the rising prevalence of the blood disorders. Development of high-sensitivity POC coagulation testing techniques will also augment the coagulation testing market during the given forecast period. However, high cost of the instruments coupled with the dearth of skilled work force might restrain the market for coagulation testing during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global coagulation testing market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global coagulation testing market.

Major industry players profiled as part of the report are Diagnostica Stago, S.A.S., Sekisui Medical Co., Ltd. and Tcoag Ireland Ltd. among others.


By Test Type

Prothrombin Time Testing
Fibrinogen Testing
Activated Clotting Time Testing
Platelet Function Tests

By End Users

Hospitals and Clinics
Diagnostic Centres
Ambulatory Care Centres

By Geography

North America
United States

South America

United Kingdom

Middle East and Africa
Saudi Arabia

Asia Pacific
South Korea
Note: Product cover images may vary from those shown
2 of 3


  • Abbott
  • Coagulation Sciences LLC
  • Diagnostica Stago, S.A.S.
  • r2 Diagnostics
  • Roche Diagnostics
  • RUSNANO Group
  • MORE
1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. Key Findings of the Study

4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. Global Coagulation Testing Market Forecast by Test Type
5.1. Prothrombin Time Testing
5.2. Fibrinogen Testing
5.3. Activated Clotting Time Testing
5.4. Platelet Function Tests
5.5. Other

6. Global Coagulation Testing Market Forecast by End Users
6.1. Hospitals and Clinics
6.2. Diagnostic Centres
6.3. Ambulatory Care Centres

7. Global Coagulation Testing Market Forecast by Geography (US$ billion)
7.1. North America
7.1.1. The U.S
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. U.K.
7.3.2. France
7.3.3. Germany
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. UAE
7.4.3. Israel
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. India
7.5.3. Australia
7.5.4. South Korea
7.5.5. Others

8. Competitive intelligence
8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals

9. Company Profiles
9.1. Abbott
9.1.1. Overview
9.1.2. Financials
9.1.3. Product and Services
9.1.4. Recent Developments
9.2. Diagnostica Stago, S.A.S.
9.2.1. Overview
9.2.2. Financials
9.2.3. Product and Services
9.2.4. Recent Developments
9.3. Roche Diagnostics
9.3.1. Overview
9.3.2. Financials
9.3.3. Product and Services
9.3.4. Recent Developments
9.4. Thermo Fisher Scientific
9.4.1. Overview
9.4.2. Financials
9.4.3. Product and Services
9.4.4. Recent Developments
9.5. r² Diagnostics
9.5.1. Overview
9.5.2. Financials
9.5.3. Product and Services
9.5.4. Recent Developments
9.6. Sekisui Medical Co., Ltd.
9.6.1. Overview
9.6.2. Financials
9.6.3. Product and Services
9.6.4. Recent Developments
9.7. Tcoag Ireland Ltd.
9.7.1. Overview
9.7.2. Financials
9.7.3. Product and Services
9.7.4. Recent Developments
9.8. Coagulation Sciences LLC
9.8.1. Overview
9.8.2. Financials
9.8.3. Product and Services
9.8.4. Recent Developments
9.9. RUSNANO Group
9.9.1. Overview
9.9.2. Financials
9.9.3. Product and Services
9.9.4. Recent Developments
9.10. Universal Biosensors
9.10.1. Overview
9.10.2. Financials
9.10.3. Product and Services
9.10.4. Recent Developments
Note: Product cover images may vary from those shown
3 of 3


4 of 3
  • Abbott
  • Diagnostica Stago, S.A.S.
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • r2 Diagnostics
  • Sekisui Medical Co. Ltd.
  • Tcoag Ireland Ltd.
  • Coagulation Sciences LLC
  • RUSNANO Group
  • Universal Biosensors
Note: Product cover images may vary from those shown